1. Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis

   • M. Grandoch
   • J. Hoffmann
   • J. W. Fischer

   Original Contribution 26 February 2013 Article: 340

   

2. Islet1 is a direct transcriptional target of the homeodomain transcription factor Shox2 and rescues the Shox2-mediated bradycardia

   • Sandra Hoffmann
   • Ina M. Berger
   • Gudrun Rappold

   Original Contribution Open access 01 March 2013 Article: 339

   

3. Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway

   • Ke Chen
   • Lu Gao
   • Hongliang Li

   Original Contribution 22 February 2013 Article: 338

   

4. Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G

   • Carmen Methner
   • Robert Lukowski
   • Thomas Krieg

   Original Contribution 20 February 2013 Article: 337

   

5. Electrical storm: recent pathophysiological insights and therapeutic consequences

   • Yukiomi Tsuji
   • Jordi Heijman
   • Dobromir Dobrev

   Review 21 February 2013 Article: 336

   

6. RETRACTED ARTICLE: Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy

   • Asli F. Ceylan-Isik
   • Maolong Dong
   • Jun Ren

   Original Contribution 05 February 2013 Article: 335

   

7. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells

   • Elena Piegari
   • Antonella De Angelis
   • Francesco Rossi

   Original Contribution 15 February 2013 Article: 334

   

8. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways

   • Zheng Zhang
   • Shuang Li
   • Feng Cao

   Original Contribution 06 February 2013 Article: 333

   

9. Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise

   • Steve R. Roof
   • Lifei Tang
   • Mark T. Ziolo

   Original Contribution 04 February 2013 Article: 332

   

10. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection

    • Robert M. Bell
    • Suma P. Kunuthur
    • Derek M. Yellon

    Original Contribution 30 January 2013 Article: 331

    

11. Endothelial NOS (NOS3) impairs myocardial function in developing sepsis

    • Annette M. van de Sandt
    • Rainer Windler
    • Marc W. Merx

    Original Contribution Open access 10 February 2013 Article: 330

    

12. Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans

    • Antje Ludwig
    • Wolfram C. Poller
    • Verena Stangl

    Original Contribution 12 January 2013 Article: 328

    

13. Erratum to: Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo

    • Dirk Westermann
    • Peter Moritz Becher
    • Carsten Tschöpe

    Erratum 25 January 2013 Article: 327

    

14. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy

    • Jing Lu
    • Zhou-Yan Bian
    • Hongliang Li

    Original Contribution 11 January 2013 Article: 326

    

15. Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction

    • Tatyana Novoyatleva
    • Yves Schymura
    • Felix B. Engel

    Original Contribution Open access 17 January 2013 Article: 325